Aim:To identify novel small compound inhibitor of p53 protein.Methods:Mouse embryonic fibroblasts (MEF) and mouse embryonic stem (ES) cells were tested. Cell proliferation rate was determined using a Cell Proliferation Kit. The mRNA and protein levels of p53-related genes were measured using real-time PCR and Western blotting, respectively. Global response in the p53 signaling network was analyzed using Illumina whole-genome expression BeadChips.Results:Treatment of MEF cells with a small molecule 1,4-bis-[4-(3-phenoxy-propoxy)-but-2-ynyl]- piperazine (G5) at 10 μmol/L for 24 h markedly reduced the mRNA and protein levels of the p53 downstream genes MDM2 and p21. In G5-treated ES cells, a total of 372 differentially expressed genes were identified, and 18 among them were direct downstream genes of p53; 6 out of 9 p53-repressed genes were upregulated, and 5 out of 9 p53-activated genes were downregulated. In both MEF cells and ES cells, treatment of with G5 (10 μmol/L) up to 48 h neither affected the proliferation rate nor caused morphological alterations.Conclusion:G5 inhibits p53 activity and simultaneously preserves the normal growth and proliferation of cells, therefore is a new compound for studies of p53-mediated cell manipulation. © 2013 CPS and SIMM.
CITATION STYLE
Liu, X., Zhang, Y., Tong, M., Liu, X. Y., Luo, G. Z., Xie, D. F., … Wang, X. J. (2013). Identification of a small molecule 1,4-bis-[4-(3-phenoxy-propoxy)-but-2- ynyl]-piperazine as a novel inhibitor of the transcription factor p53. Acta Pharmacologica Sinica, 34(6), 805–810. https://doi.org/10.1038/aps.2013.61
Mendeley helps you to discover research relevant for your work.